# Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust Mites

> **NCT07475715** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.** · enrollment: 250 (estimated)

## Conditions studied

- Allergic Rhinitis Due to Dust Mite

## Interventions

- **BIOLOGICAL:** Sublingual Film for Dermatophagoides pteronyssinus
- **BIOLOGICAL:** Sublingual Film for Dermatophagoides pteronyssinus
- **BIOLOGICAL:** Sublingual Film for Dermatophagoides pteronyssinus
- **BIOLOGICAL:** Sublingual Film for Dermatophagoides pteronyssinus
- **BIOLOGICAL:** Sublingual Film for Dermatophagoides pteronyssinus placebo

## Key facts

- **NCT ID:** NCT07475715
- **Lead sponsor:** Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-12-07
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475715, "Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust Mites". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07475715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*